Literature DB >> 324400

Side effects of minocycline: a double-blind study.

W L Fanning, D W Gump, R A Sofferman.   

Abstract

We studied the incidence and type of side effects of minocycline in a double-blind study. A total of 45 volunteers (18 men and 27 women) were given minocycline, and 44 volunteers (23 men and 21 women) were given placebo. The men in both the minocycline and placebo groups were significantly (P < 0.0001) larger than the women in the comparable groups. Minocycline dosage was 100 mg every 12 h for 5 days, and placebo was administered in an identical manner. Minocycline serum concentrations were determined in 12 volunteers at 1, 2, 4, and 6 h after the morning doses on days 1, 3, and 5 of the study. Side effects were recorded by volunteers in diaries and also through daily interviews and were evaluated by examination and electronystagmography. Peak minocycline serum concentrations were seen by day 3 and correlated with the peak onset of side effects. These concentrations were significantly higher in women than in men. Vestibular side effects occurred in 70.4% of the women on minocycline and significantly (P < 0.0001) exceeded the rate of the women on placebo (9.5%). Only loss of balance was significantly (P < 0.05) increased in the men taking minocycline as contrasted with men on placebo. Electronystagmography generally revealed no abnormalities. Side effects were usually not severe: four volunteers in the minocycline group and two in the placebo group discontinued their capsules because of side effects. It is concluded that women experience an unacceptably high incidence of side effects from minocycline, and this may be related to their higher serum concentrations, which in turn may relate to their smaller size.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324400      PMCID: PMC352056          DOI: 10.1128/AAC.11.4.712

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Vestibular reactions associated with minocycline.

Authors:  J A Jacobson; B Daniel
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

Authors:  M Barza; R B Brown; C Shanks; C Gamble; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

3.  Distressing side-effects of minocycline hydrochloride.

Authors:  W L Fanning; D W Gump
Journal:  Arch Intern Med       Date:  1976-07

4.  Eradication of carriage of Neisseria meningitidis in families: a study in Brazil.

Authors:  R S Munford; Z J Sussuarana de Vasconcelos; C J Phillips; D S Gelli; G W Gorman; J B Risi; R A Feldman
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Minocycline: Possible vestibular side-effects.

Authors:  D N Williams; L W Laughlin; Y H Lee
Journal:  Lancet       Date:  1974-09-28       Impact factor: 79.321

6.  The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel.

Authors:  L F Devine; D P Johnson; C R Hagerman; W E Pierce; S L Rhode; R O Peckinpaugh
Journal:  Am J Epidemiol       Date:  1971-05       Impact factor: 4.897

7.  Clinical pharmacologic studies with minocycline.

Authors:  B Bernard; E J Yin; H J Simon
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Sep-Oct

8.  Effect of rifampin and minocycline on meningococcal carrier rates.

Authors:  R B Guttler; G W Counts; C K Avent; H N Beaty
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

9.  Minocycline in the chemoprophylaxis of meningococcal disease.

Authors:  R B Guttler; H N Beaty
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

  9 in total
  11 in total

Review 1.  Neurologic Complications of Commonly Used Drugs in the Hospital Setting.

Authors:  Elliot T Dawson; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

2.  Side effects of minocycline: different dosage regimens.

Authors:  D W Gump; T Ashikaga; T J Fink; A M Radin
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

Review 3.  Glial Cells Shape Pathology and Repair After Spinal Cord Injury.

Authors:  Andrew D Gaudet; Laura K Fonken
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

4.  The effect of minocycline on potassium leakage from red cells: a study of the genetics and relationship to vestibular adverse reactions.

Authors:  B G Lannigan; D A Evans
Journal:  J Med Genet       Date:  1982-10       Impact factor: 6.318

5.  Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers.

Authors:  M P Pugsley; D L Dworzack; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 6.  Minocycline for acne vulgaris: efficacy and safety.

Authors:  Sarah E Garner; Anne Eady; Cathy Bennett; John Norman Newton; Karen Thomas; Catalin Mihai Popescu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 7.  Guidelines for the management of acne vulgaris in adolescents.

Authors:  Victoria Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury.

Authors:  Erzsebet Kovesdi; Alaa Kamnaksh; Daniel Wingo; Farid Ahmed; Neil E Grunberg; Joseph B Long; Christine E Kasper; Denes V Agoston
Journal:  Front Neurol       Date:  2012-07-16       Impact factor: 4.003

9.  The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.

Authors:  Danuta M Lisiecka; John Suckling; Thomas R E Barnes; Imran B Chaudhry; Paola Dazzan; Nusrat Husain; Peter B Jones; Eileen M Joyce; Stephen M Lawrie; Rachel Upthegrove; Bill Deakin
Journal:  Trials       Date:  2015-03-02       Impact factor: 2.279

10.  An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome.

Authors:  Joseph C Grieco; Stephanie L Ciarlone; Maria Gieron-Korthals; Mike R Schoenberg; Amanda G Smith; Rex M Philpot; Helen S Heussler; Jessica L Banko; Edwin J Weeber
Journal:  BMC Neurol       Date:  2014-12-10       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.